SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-020033
Filing Date
2021-02-10
Accepted
2021-02-10 20:01:02
Documents
1
Period of Report
2021-02-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm216079d1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm216079d1_4seq1.xml 4 7962
  Complete submission text file 0001104659-21-020033.txt   9592
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 HAZELWOOD COURT WARREN NJ 07059
Business Address
Miller Larry Lee (Reporting) CIK: 0001603584 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 21615989